Project investment

Vessl

Vessl’s Medical technology belongs to the field of regenerative medicine and incorporates both cell therapy and gene therapy. Vessl uses vascular endothelial cells to activate genes for therapeutic purposes by growing new compatible vectors/grafts through grafting.

BrainQ

BrainQ is an Israeli company, developed neuro-recovery technology for various neurological diseases. The core of the company’s technology is related to the identification of high-resolution spectra in brain waves and it has developed the world’s largest database of electroencephalography (EEG) motion tasks for brain-computer interface programs.

Neshima

Acute respiratory distress syndrome (ARDS) is a lung disease with a high mortality rate and difficult recovery. Pneumonia, inhalation, and drowning are all contributing factors to ARDS. How effectively surfactant is delivered to the lungs is key to alleviating the disease. Currently, due to the lack of effective treatment options for ARDS, care and rehabilitation …

Read moreNeshima

VEGF

Israeli scientist Eli Keshet discovered that using vascular cell growth factor (VEGF) to help maintain vascular stability can be an effective and comprehensive way to combat aging. Current animal studies have shown that increasing intravascular VEGF levels can effectively reduce a number of problems triggered by aging such as capillary loosening, liver damage, loss of …

Read moreVEGF

AMD

Dry age-related macular degeneration (AMD) is a chronic neurodegenerative disease that can eventually lead to blindness and cellular senescence of the retinal pigment epithelium (RPE) RPE cells are thought to be an important mediator in the pathogenesis of macular degeneration. Israeli scientist Ayala Pollack and his team have investigated a novel minimally invasive therapy for …

Read moreAMD